Product NDC: | 65841-626 |
Proprietary Name: | Haloperidol |
Non Proprietary Name: | Haloperidol |
Active Ingredient(s): | 5 mg/1 & nbsp; Haloperidol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65841-626 |
Labeler Name: | Cadila Healthcare Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077580 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080103 |
Package NDC: | 65841-626-10 |
Package Description: | 1000 TABLET in 1 BOTTLE (65841-626-10) |
NDC Code | 65841-626-10 |
Proprietary Name | Haloperidol |
Package Description | 1000 TABLET in 1 BOTTLE (65841-626-10) |
Product NDC | 65841-626 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Haloperidol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080103 |
Marketing Category Name | ANDA |
Labeler Name | Cadila Healthcare Limited |
Substance Name | HALOPERIDOL |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Typical Antipsychotic [EPC] |